Epidemiology journal articles 2003

Breast Cancer

Colleoni M, Curigliano G, Minchella I, Peruzzotti G, Nole F, Mazzarol G, Renne G, Orlando L, Rocca A, Veronesi P, Intra M, Viale G, Sandri MT, Severi G, Goldhirsch A. Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: Cytotoxic treatment during the surgical phase. Ann Oncol. 2003;14:1477-1483

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst. 2003;95:448-457

Giles GG, Amos A. Evaluation of the organised mammographic screening programme in Australia. Ann Oncol. 2003;14:1209-1211

Leonardi MC, Brambilla MG, Zurrida S, Intra M, Frasson A, Severi G, Robertson C, Orecchia R. Analysis of irradiated lung and heart volumes using virtual simulation in postoperative treatment of stage I breast carcinoma. Tumori. 2003;89:60-67

McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL. Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer. 2003;89:1661-1663

Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years. Cancer Epidemiol Biomarkers Prev. 2003;12:1109-1111

Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE. Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. Eur J Cancer. 2003;39:622-630

Scott CI, Iorgulescu DG, Thorne HJ, Henderson MA, Phillips KA. Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy. Clin Genet. 2003;64:111-121

Southey MC, Tesoriero A, Young MA, Holloway AJ, Jenkins MA, Whitty J, Misfud S, kConFab, McLachlan SA, Venter DJ, Armes JE. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1. Hum Mutat. 2003;22:86-91

Colorectal Cancer

Haydon A. Adjuvant chemotherapy in colon cancer: What is the evidence? Intern Med J. 2003;33:119-124

Moot AR, Polglase A, Giles GG, Garson OM, Thursfield V, Gunter D. Men with colorectal cancer are predisposed to prostate cancer. ANZ J Surg. 2003;73:289-293

Prostate Cancer

Bevan S, Edwards SM, Ardern Jones A, Dowe A, Southgate C, Dearnaley D, Easton DF, Houlston RS, Eeles RA. Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer. Prostate Cancer Prostatic Dis. 2003;6:12-14

Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am. 2003;30:209-217

Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL. Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a cyp17 polymorphism and breast cancer. Genet Epidemiol. 2003;24:161-172

Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ. Where are the prostate cancer genes?--a summary of eight genome wide searches. Prostate. 2003;57:261-269

Edwards S, Meitz J, Eles R, Evans C, Easton D, Hopper J, Giles G, Foulkes WD, Narod S, Simard J, Badzioch M, Mahle L. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. Prostate. 2003;57:270-279

Giles GG, Severi G, English DR, McCredie MR, Borland R, Boyle P, Hopper JL. Sexual factors and prostate cancer. BJU Int. 2003;92:211-216

Giles GG, Severi G, English DR, McCredie MR, MacInnis R, Boyle P, Hopper JL. Early growth, adult body size and prostate cancer risk. Int J Cancer. 2003;103:241-245

MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:1417-1421

Severi G, Giles GG, Southey MC, Tesoriero A, Tilley W, Neufing P, Morris H, English DR, McCredie MR, Boyle P, Hopper JL. ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J Natl Cancer Inst. 2003;95:818-824

Staples MP, Giles GG, English DR, McCredie MR, Severi G, Cui JS, Hopper JL. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes Control. 2003;14:161-166

Other Cancer

Autier P, Severi G, Pedeux R, Cattaruzza MS, Boniol M, Grivegnee A, Dore JF, European Organisation for R, Treatment of Cancer Melanoma G. Number and size of nevi are influenced by different sun exposure components: Implications for the etiology of cutaneous melanoma (Belgium, Germany, France, Italy). Cancer Causes Control. 2003;14:453-459

Boyle P, d'Onofrio A, Maisonneuve P, Severi G, Robertson C, Tubiana M, Veronesi U. Measuring progress against cancer in Europe: Has the 15% decline targeted for 2000 come about? Ann Oncol. 2003;14:1312-1325

English DR, Burton RC, del Mar CB, Donovan RJ, Ireland PD, Emery G. Evaluation of aid to diagnosis of pigmented skin lesions in general practice: Controlled trial randomised by practice. BMJ. 2003;327:375

Garaventa A, Luksch R, Biasotti S, Severi G, Pizzitola MR, Viscardi E, Prete A, Mastrangelo S, Podda M, Haupt R, De Bernardi B. A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma. Cancer. 2003;98:2488-2494

Heenan PJ. Author response to: Nodular melanoma is not a distinct entity [letter]. Arch Dermatol. 2003;139:387; author reply 387-388

Johnston R, Cross D, Costa C, Giles-Corti B, Cordin T, Milne E, English DR. Sun safety education intervention for school and home. Health Educ. 2003;103:342-351

Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer. 2003;105:117-122

Other Conditions

Ball K, Crawford D, Ireland P, Hodge A. Patterns and demographic predictors of 5-year weight change in a multi-ethnic cohort of men and women in Australia. Public Health Nutr. 2003;6:269-281

Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension. 2003;41:207-210

Flicker L, Mead K, MacInnis RJ, Nowson C, Scherer S, Stein MS, Thomasx J, Hopper JL, Wark JD. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc. 2003;51:1533-1538

Lawes CM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, Suh I, Rodgers A. Blood pressure indices and cardiovascular disease in the Asia Pacific region: A pooled analysis. Hypertension. 2003;42:69-75

Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707-716

MacInnis RJ, Cassar C, Nowson CA, Paton LM, Flicker L, Hopper JL, Larkins RG, Wark JD. Determinants of bone density in 30- to 65-year-old women: A co-twin study. J Bone Miner Res. 2003;18:1650-1656

Minicucci L, Severi G, Cresta L, Giannattasio A, Lorini R, Haupt R. Impact of inhaled corticosteroids on the risk of early pseudomonas aeruginosa acquisition in cystic fibrosis. Acta paediatrica. 2003;92:684-687

Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG. Androgenetic alopecia in men aged 40-69 years: Prevalence and risk factors. Br J Dermatol. 2003;149:1207-1213

Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, MacMahon S. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003;26:360-366

Zhang X, Patel A, Horibe H, Wu Z, Barzi F, Rodgers A, MacMahon S, Woodward M. Cholesterol, coronary heart disease, and stroke in the Asia-Pacific region. Int J Epidemiol. 2003;32:563-572

Updated: 07 Nov, 2013